Syndrome d'encéphalopathie postérieure réversible ou <i>Posterior Reversible Encephalopathy Syndrome</i> (PRES) secondaire au bevacizumab
Crossref DOI link: https://doi.org/10.1007/s13341-017-0788-3
Published Online: 2017-10-09
Published Print: 2018-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Peyrony, O.
de Margerie-Mellon, C.
Mariotte, E.
License valid from 2017-10-09